Fear, anxiety, stress, and burnout can all happen to parents of children with sickle cell disease, writes columnist.

Disc Medicine is planning to launch a trial by year's end to test DISC-3405, its treatment candidate for iron overload, in ...

Wilson writes that withdrawing has been for him a way to feel safe, but frustrated his ability to connect to others.

Invisible Disabilities Week may have passed by unnoticed, but many of us live it every day, writes columnist Mary Shaniqua.

Testing for PlGF levels can predict the risk of early-onset preeclampsia during pregnancy in people with sickle cell disease, ...

Columnist Mary Shaniqua offers up ideas for managing sickle cell disease to get the most out of busy end-of-year events.

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

Tocilizumab was effectively used off-label in four young adults with sickle cell disease (SCD) to treat hyperhemolysis ...

How quickly time flies! I can hardly believe I’ve nearly completed another trip around the sun. It feels like only yesterday I was penning my thoughts for my 38th birthday column. I’m overwhelmed with ...

Sickle cell disease is classified as a rare condition. Yet, for a long time, that was hard for me to believe, especially during my teenage years. Growing up in South London, a city with a large Black ...

People with sickle cell disease (SCD) seeking emergency care for vaso-occlusive crises (VOCs) are often not triaged appropriately, leading to unnecessarily long waits for pain relief. A recent study ...